ClinTrial Refer LYSA Application icon

ClinTrial Refer LYSA 1.0.2

6.2 MB / 1+ Downloads / Rating 1.0 - 1 reviews


See previous versions

ClinTrial Refer LYSA, developed and published by Haematology Clinical Research Network NSW, has released its latest version, 1.0.2, on 2016-10-25. This app falls under the Medical category on the Google Play Store and has achieved over 100 installs. It currently holds an overall rating of 1.0, based on 1 reviews.

ClinTrial Refer LYSA APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.lps.clintrialsrefer.lysa

Updated: 8 years ago

Developer Name: Haematology Clinical Research Network NSW

Category: Medical

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing ClinTrial Refer LYSA on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

App Rating

1.0
Total 1 reviews

Previous Versions

ClinTrial Refer LYSA 1.0.2
2016-10-25 / 6.2 MB / Android 2.3+

About this app

LYSARC (Lymphoma Studies Academic Research Company) was founded in 2012 following the merger of two leading academic groups (GELA and GOELAMS) who decided to combine their clinical experience, methodological expertise and access to patients. This merger created a world-class specialist research organization in the field of lymphoma. LYSARC objective is to improve the access of innovative therapies for lymphoma patients. LYSARC is a nonprofit trust governed by an independent Board composed of leading clinicians and pathologists with international reputation in the field of lymphoma research. For each trial, you will find the acronym, title of trial, population, trials details, inclusion and exclusion criteria.

App Permissions

Allows applications to open network sockets.
Allows applications to access information about networks.
Allows an application to write to external storage.
Allows an application to read from external storage.
Allows access to the list of accounts in the Accounts Service.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.
Allows access to the vibrator.